VIROPHARMA INC: eps_basic
| Value | {"per": "shares", "amount": 0.16, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-09-30 |
| Status | superseded |
| Entity | VIROPHARMA INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b43f0b73-c71e-4f4b-82bb-072f3e9dbe33
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-435221 · Open the official SEC filing →Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000946840/eps-basic/2012-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b43f0b73-c71e-4f4b-82bb-072f3e9dbe33
History
- no predecessors — first report